全文获取类型
收费全文 | 53399篇 |
免费 | 3326篇 |
国内免费 | 296篇 |
专业分类
耳鼻咽喉 | 524篇 |
儿科学 | 1526篇 |
妇产科学 | 1351篇 |
基础医学 | 7033篇 |
口腔科学 | 1521篇 |
临床医学 | 5330篇 |
内科学 | 11309篇 |
皮肤病学 | 1250篇 |
神经病学 | 5554篇 |
特种医学 | 1661篇 |
外科学 | 6595篇 |
综合类 | 214篇 |
一般理论 | 24篇 |
预防医学 | 4510篇 |
眼科学 | 898篇 |
药学 | 3374篇 |
1篇 | |
中国医学 | 139篇 |
肿瘤学 | 4207篇 |
出版年
2024年 | 57篇 |
2023年 | 527篇 |
2022年 | 933篇 |
2021年 | 2011篇 |
2020年 | 1209篇 |
2019年 | 1687篇 |
2018年 | 1927篇 |
2017年 | 1357篇 |
2016年 | 1571篇 |
2015年 | 1821篇 |
2014年 | 2461篇 |
2013年 | 3130篇 |
2012年 | 4633篇 |
2011年 | 4770篇 |
2010年 | 2428篇 |
2009年 | 2205篇 |
2008年 | 3698篇 |
2007年 | 3676篇 |
2006年 | 3305篇 |
2005年 | 3229篇 |
2004年 | 2707篇 |
2003年 | 2392篇 |
2002年 | 2147篇 |
2001年 | 294篇 |
2000年 | 215篇 |
1999年 | 298篇 |
1998年 | 361篇 |
1997年 | 278篇 |
1996年 | 240篇 |
1995年 | 211篇 |
1994年 | 192篇 |
1993年 | 153篇 |
1992年 | 106篇 |
1991年 | 104篇 |
1990年 | 82篇 |
1989年 | 68篇 |
1988年 | 52篇 |
1987年 | 57篇 |
1986年 | 49篇 |
1985年 | 42篇 |
1984年 | 53篇 |
1983年 | 33篇 |
1982年 | 48篇 |
1981年 | 35篇 |
1980年 | 27篇 |
1979年 | 22篇 |
1978年 | 16篇 |
1977年 | 15篇 |
1976年 | 9篇 |
1972年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 609 毫秒
51.
Regina Gershkovich David Sacks Abraham Chlibovsky Sonia Yudaev Asher Korzets 《Nephrology, dialysis, transplantation》2006,21(2):539-540
Case report A 28-year-old female patient was admitted because of painlessmacroscopic haematuria. Past history included severe mentalretardation and nystagmus. At age 17, a computed tomography(CT) scan of the brain showed an absent cerebellar vermis andcerebellar hypoplasia. There was no 相似文献
52.
53.
Susan M Domchek Andrea Eisen Kathleen Calzone Jill Stopfer Anne Blackwood Barbara L Weber 《Journal of clinical oncology》2003,21(4):593-601
Breast cancer risk assessment provides an estimation of disease risk that can be used to guide management for women at all levels of risk. In addition, the likelihood that breast cancer risk is due to specific genetic susceptibility (such as BRCA1 or BRCA2 mutations) can be determined. Recent developments have reinforced the clinical importance of breast cancer risk assessment. Tamoxifen chemoprevention as well as prevention studies such as the Study of Tamoxifen and Raloxifene are available to women at increased risk of developing breast cancer. In addition, specific management strategies are now defined for BRCA1 and BRCA2 mutation carriers. Risk may be assessed as the likelihood of developing breast cancer (using risk assessment models) or as the likelihood of detecting a BRCA1 or BRCA2 mutation (using prior probability models). Each of the models has advantages and disadvantages, and all need to be interpreted in context. We review available risk assessment tools and discuss their application. As illustrated by clinical examples, optimal counseling may require the use of several models, as well as clinical judgment, to provide the most accurate and useful information to women and their families. 相似文献
54.
Andrea R Genazzani Hermann P G Schneider Nick Panay Esme A Nijland 《Gynecological endocrinology》2006,22(7):369-375
OBJECTIVES: To identify and describe current women's thoughts about the menopause, hormone treatment (HT) and perceptions about breast cancer. METHODS: Between December 2004 and January 2005, 4201 postmenopausal women in seven European countries were interviewed via a standardized computer-aided telephone interview protocol. RESULTS: Almost all women reported to have experienced climacteric symptoms, and 63% of the women rated them as being severe. Only 52% of women were aware of the benefits of HT for relief of climacteric symptoms. Although 84% felt that severe symptoms should be treated, only 40% had used HT at some point in time. Thirty-four percent of the women preferring treatment with natural products did so because of the risk of breast cancer associated with HT. HT was recognized by 59% of the women as one of the most important contributors to an increased breast cancer risk. Most women received their information about HT and breast cancer risk from the media. CONCLUSIONS: This European survey reveals that the majority of women experience climacteric symptoms but that their decision whether or not to use HT is highly dependent on their concern about breast cancer risk. An increase in knowledge of the benefits and risks of HT is required for women to make appropriate decisions about hormone use. 相似文献
55.
Young women with endometriosis have reduced cortical and trabecular bone mineral density of the wrist compared with age-matched controls. This conclusion was based on 41 subjects from one geographical location. The purpose of this study was to test this finding in a larger, more geographically diverse population. One hundred women with laparoscopically proven endometriosis were enrolled in this study for the evaluation of the efficacy of nafarelin, a gonadotropin-releasing hormone agonist. Patients were recruited from nine investigators across the United States and Canada, and bone mineral density of the lumbar spine was obtained at baseline, with 6 Hologic QDR (Hologic Inc., Waltham, MA) and a Lunar DPX (Lunar Radiation Corp., Madison, WI) instrument. The age of the women was 30.3 +/- 5.8 years (mean +/- SD); 91% were white. Bone mineral density of the lumbar spine was 1.1 +/- 0.11 g/cm2 (n = 85 Hologic QDR) and 1.2 +/- 0.93 g/cm2 (n = 15 Lunar DPX). Hologic bone mineral density was 104.8 +/- 11.0 and Lunar bone mineral density was 103.4% +/- 7.8% of normal values for age. To conclude, in a population based cross-sectional study of patients with endometriosis, we do not observe low bone mineral density of the lumbar spine by techniques that measure a combination of cortical and trabecular bone. 相似文献
56.
57.
58.
59.
Joseph F Malouf Manfredi Ballo Heidi M Connolly David O Hodge Regina M Herges Charles J Mullany Fletcher A Miller 《Journal of the American Society of Echocardiography》2005,18(3):252-256
The purpose of this study was to provide, in a large number of patients, comprehensive Doppler echocardiographic assessment of normal St Jude Medical mitral valve prosthesis function using Doppler-derived hemodynamic variables, including the mitral valve prosthesis-to-left ventricular outflow tract time-velocity integral ratio and prosthesis performance index. The pressure half-time was less than 130 milliseconds in all patients, and all but one patient had either a peak early mitral diastolic velocity of 2 m/s or less or a mitral valve prosthesis-to-left ventricular outflow tract time-velocity integral ratio of less than 2.2. There was a significant (P < .001) negative correlation between the prosthesis performance index and prosthesis size. This negative correlation suggests that there is more efficient use of the in vitro geometric orifice area with smaller prostheses. 相似文献
60.